|
Real-time
Oslo Bors
13:51:19 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.5680 NOK | 0.00% |
|
-0.35% | -86.79% |
| 10-13 | Induct AS Expands Scope of Existing Severe Asthma Care Pathway | CI |
| 08-13 | Induct AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Evolution of the Average Target: Induct
Evolution of the Target Price: Induct
Changes in Analyst Recommendations: Induct
bc0afbddc7d4cf908e6550.tWWBtZpkNwI6QuZN0y_MpL4_PbUj9MTK_jSG24MCqdM.4jL53-gqbltzKbF5q1614ZMMa-1yn6aulALjqM1m5qaDEOX38hBkQQsRkQ~624b7344c4284b08a5d077fd31f26c9c
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +76.06% | |||
| +13.89% | |||||
| +5.15% | |||||
| +80.65% | |||||
| -0.79% | |||||
| +12.1% | |||||
| -7.75% | |||||
| +1.51% | |||||
| -8.41% | |||||
| +9.64% | |||||
| Average | +18.21% | |||||
| Weighted average by Cap. | +14.80% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5680NOK
Average target price
1.000NOK
Spread / Average Target
+76.06%
High Price Target
1.000NOK
Spread / Highest target
+76.06%
Low Price Target
1.000NOK
Spread / Lowest Target
+76.06%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- INDCT Stock
- Consensus Induct
Select your edition
All financial news and data tailored to specific country editions
